Transient suppression of TGFβ receptor signaling facilitates human islet transplantation

Xiangwei Xiao, Shane Fischbach, Zewen Song, Iljana Gaffar, Ray Zimmerman, John Wiersch, Krishna Prasadan, Chiyo Shiota, Ping Guo, Sabarinathan Ramachandran, Piotr Witkowski, George K. Gittes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Although islet transplantation is an effective treatment for severe diabetes, its broad application is greatly limited due to a shortage of donor islets. Suppression of TGFβ receptor signaling in β-cells has been shown to increase β-cell proliferation in mice, but has not been rigorously examined in humans. Here, treatment of human islets with a TGFβ receptor I inhibitor, SB-431542 (SB), significantly improved C-peptide secretion by β-cells, and significantly increased β-cell number by increasing β-cell proliferation. In addition, SB increased cell-cycle activators and decreased cell-cycle suppressors in human β-cells. Transplantation of SB-treated human islets into diabetic immunedeficient mice resulted in significant improvement in blood glucose control, significantly higher serum and graft insulin content, and significantly greater increases in β-cell proliferation in the graft, compared with controls. Thus, our data suggest that transient suppression of TGFβ receptor signaling may improve the outcome of human islet transplantation, seemingly through increasing β-cell number and function.

Original languageEnglish (US)
Pages (from-to)1348-1356
Number of pages9
JournalEndocrinology
Volume157
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Islets of Langerhans Transplantation
Cell Proliferation
Cell Cycle
Cell Count
Transplants
C-Peptide
Blood Glucose
Transplantation
Insulin
Therapeutics
Serum

Cite this

Xiao, X., Fischbach, S., Song, Z., Gaffar, I., Zimmerman, R., Wiersch, J., ... Gittes, G. K. (2016). Transient suppression of TGFβ receptor signaling facilitates human islet transplantation. Endocrinology, 157(4), 1348-1356. https://doi.org/10.1210/en.2015-1986

Transient suppression of TGFβ receptor signaling facilitates human islet transplantation. / Xiao, Xiangwei; Fischbach, Shane; Song, Zewen; Gaffar, Iljana; Zimmerman, Ray; Wiersch, John; Prasadan, Krishna; Shiota, Chiyo; Guo, Ping; Ramachandran, Sabarinathan; Witkowski, Piotr; Gittes, George K.

In: Endocrinology, Vol. 157, No. 4, 01.04.2016, p. 1348-1356.

Research output: Contribution to journalArticle

Xiao, X, Fischbach, S, Song, Z, Gaffar, I, Zimmerman, R, Wiersch, J, Prasadan, K, Shiota, C, Guo, P, Ramachandran, S, Witkowski, P & Gittes, GK 2016, 'Transient suppression of TGFβ receptor signaling facilitates human islet transplantation', Endocrinology, vol. 157, no. 4, pp. 1348-1356. https://doi.org/10.1210/en.2015-1986
Xiao X, Fischbach S, Song Z, Gaffar I, Zimmerman R, Wiersch J et al. Transient suppression of TGFβ receptor signaling facilitates human islet transplantation. Endocrinology. 2016 Apr 1;157(4):1348-1356. https://doi.org/10.1210/en.2015-1986
Xiao, Xiangwei ; Fischbach, Shane ; Song, Zewen ; Gaffar, Iljana ; Zimmerman, Ray ; Wiersch, John ; Prasadan, Krishna ; Shiota, Chiyo ; Guo, Ping ; Ramachandran, Sabarinathan ; Witkowski, Piotr ; Gittes, George K. / Transient suppression of TGFβ receptor signaling facilitates human islet transplantation. In: Endocrinology. 2016 ; Vol. 157, No. 4. pp. 1348-1356.
@article{3791db0d2b6041d8a2438e20cd6b9e17,
title = "Transient suppression of TGFβ receptor signaling facilitates human islet transplantation",
abstract = "Although islet transplantation is an effective treatment for severe diabetes, its broad application is greatly limited due to a shortage of donor islets. Suppression of TGFβ receptor signaling in β-cells has been shown to increase β-cell proliferation in mice, but has not been rigorously examined in humans. Here, treatment of human islets with a TGFβ receptor I inhibitor, SB-431542 (SB), significantly improved C-peptide secretion by β-cells, and significantly increased β-cell number by increasing β-cell proliferation. In addition, SB increased cell-cycle activators and decreased cell-cycle suppressors in human β-cells. Transplantation of SB-treated human islets into diabetic immunedeficient mice resulted in significant improvement in blood glucose control, significantly higher serum and graft insulin content, and significantly greater increases in β-cell proliferation in the graft, compared with controls. Thus, our data suggest that transient suppression of TGFβ receptor signaling may improve the outcome of human islet transplantation, seemingly through increasing β-cell number and function.",
author = "Xiangwei Xiao and Shane Fischbach and Zewen Song and Iljana Gaffar and Ray Zimmerman and John Wiersch and Krishna Prasadan and Chiyo Shiota and Ping Guo and Sabarinathan Ramachandran and Piotr Witkowski and Gittes, {George K.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1210/en.2015-1986",
language = "English (US)",
volume = "157",
pages = "1348--1356",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Transient suppression of TGFβ receptor signaling facilitates human islet transplantation

AU - Xiao, Xiangwei

AU - Fischbach, Shane

AU - Song, Zewen

AU - Gaffar, Iljana

AU - Zimmerman, Ray

AU - Wiersch, John

AU - Prasadan, Krishna

AU - Shiota, Chiyo

AU - Guo, Ping

AU - Ramachandran, Sabarinathan

AU - Witkowski, Piotr

AU - Gittes, George K.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Although islet transplantation is an effective treatment for severe diabetes, its broad application is greatly limited due to a shortage of donor islets. Suppression of TGFβ receptor signaling in β-cells has been shown to increase β-cell proliferation in mice, but has not been rigorously examined in humans. Here, treatment of human islets with a TGFβ receptor I inhibitor, SB-431542 (SB), significantly improved C-peptide secretion by β-cells, and significantly increased β-cell number by increasing β-cell proliferation. In addition, SB increased cell-cycle activators and decreased cell-cycle suppressors in human β-cells. Transplantation of SB-treated human islets into diabetic immunedeficient mice resulted in significant improvement in blood glucose control, significantly higher serum and graft insulin content, and significantly greater increases in β-cell proliferation in the graft, compared with controls. Thus, our data suggest that transient suppression of TGFβ receptor signaling may improve the outcome of human islet transplantation, seemingly through increasing β-cell number and function.

AB - Although islet transplantation is an effective treatment for severe diabetes, its broad application is greatly limited due to a shortage of donor islets. Suppression of TGFβ receptor signaling in β-cells has been shown to increase β-cell proliferation in mice, but has not been rigorously examined in humans. Here, treatment of human islets with a TGFβ receptor I inhibitor, SB-431542 (SB), significantly improved C-peptide secretion by β-cells, and significantly increased β-cell number by increasing β-cell proliferation. In addition, SB increased cell-cycle activators and decreased cell-cycle suppressors in human β-cells. Transplantation of SB-treated human islets into diabetic immunedeficient mice resulted in significant improvement in blood glucose control, significantly higher serum and graft insulin content, and significantly greater increases in β-cell proliferation in the graft, compared with controls. Thus, our data suggest that transient suppression of TGFβ receptor signaling may improve the outcome of human islet transplantation, seemingly through increasing β-cell number and function.

UR - http://www.scopus.com/inward/record.url?scp=84964412501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964412501&partnerID=8YFLogxK

U2 - 10.1210/en.2015-1986

DO - 10.1210/en.2015-1986

M3 - Article

VL - 157

SP - 1348

EP - 1356

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 4

ER -